Webinar Leaders
House Speaker
Zer En Peng
Research Analyst
Beacon
Moderator
Harvey Dennis
Account Manager
Beacon
Speak with industry experts
What is Beacon Checkpoint?
Beacon Checkpoint is a sector-specific curated database that includes trial and drug records for preclinical, active, approved, and discontinued:
- Immune Checkpoint Modulator Combinations
- Immune Checkpoint Modulators Monotherapies
- Across over 27 different checkpoint targets
Commercial intelligence data expansion: Gain unparalleled access to in-depth company profiles and the latest commercial deals. Monitor your competitors and opportunities as well as benchmark deals and evaluate potential partners. Learn more by downloading the factsheet.
How Beacon Checkpoint works
Our intelligent search function instantly sweeps the clinical trial and drug landscape using 20 search criteria including therapeutic class, target, disease indication, developer, drug status and more. Search for combinations in trials or individual arms to avoid false positives.
The unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the checkpoint space.
If publicly available, information regarding trials where an immune checkpoint is in combination with an antibody-drug conjugate, bispecific, cell therapy or gene therapy will also be included in our trial coverage.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
